Business Context and Reporting Period
Company: Teradyne, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 28, 2008
Business Overview: Teradyne is a global supplier of automatic test equipment, operating through two primary segments: Semiconductor Test and Systems Test Group (Mil/Aero, Commercial Board Test, and Diagnostic Solutions). The company completed the acquisition of Nextest Systems Corporation in January 2008 and entered into an agreement to acquire Eagle Test Systems, Inc. in September 2008.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sep 28, 2008 |
Nine Months Ended Sep 28, 2008 |
Nine Months Ended Sep 30, 2007 |
|---|---|---|---|
| Net Revenues | $297,255 | $912,275 | $841,864 |
| Gross Profit | $127,930 | $420,281 | $394,863 |
| Gross Margin % | 43.0% | 46.1% | 46.9% |
| Operating (Loss) Income | $(17,276) | $(1,160) | $34,416 |
| Net (Loss) Income | $(22,689) | $(9,243) | $61,007 |
| Diluted EPS (Continuing Ops) | $(0.14) | $(0.06) | $0.29 |
| Cash and Cash Equivalents | $292,573 | Balance Sheet Item | |
| Total Marketable Securities | $175,403 | Balance Sheet Item | |
| Operating Cash Flow (9mo) | $119,694 |
Material Changes vs. Prior Period
- Revenue: Nine-month revenue increased 8% ($70.4 million) primarily driven by the Nextest acquisition ($61.6 million contribution). However, the Systems Test Group saw a 9% decline in revenue.
- Profitability: The company reported a net loss of $9.2 million for the nine months ended September 28, 2008, compared to net income of $61.0 million in the prior year period. This shift was driven by significant non-recurring charges.
- Restructuring Charges: Teradyne recorded $53.1 million in restructuring and other charges for the nine months ended September 28, 2008, compared to a net credit of $0.3 million in the prior year. Key components included a $22.6 million loss on the sale of real estate and $15.6 million in severance charges.
- Inventory Provisions: Provisions for excess and obsolete inventory increased significantly to $25.0 million for the nine months ended September 28, 2008, compared to $1.5 million in the prior year, due to decreased semiconductor demand forecasts.
- Investing Activities: Net cash used for investing activities was $314.6 million, primarily due to the $285.3 million cash outflow for the Nextest acquisition.
Guidance, Outlook, Risks, and Unusual Items
- Acquisitions: The company is integrating Nextest Systems Corporation and expects to close the acquisition of Eagle Test Systems, Inc. (approx. $250 million) in the fourth quarter of 2008.
- Restructuring Outlook: Restructuring actions taken in the first nine months are expected to generate quarterly cost savings of approximately $8.1 million.
- Unusual Items:
- Impairment: An $8.5 million other-than-temporary impairment loss was recognized on marketable securities (mortgage-backed and financial institution debt).
- Discontinued Operations: Results from the Broadband Test Systems division (sold in August 2007) are reported as discontinued operations.
- Risks: Management highlights risks related to the global economic downturn, volatility in financial markets affecting credit availability, and the cyclical nature of the semiconductor industry. There is also a pending patent infringement lawsuit filed by Xyratex Technology, Ltd.
- Liquidity: Cash, cash equivalents, and marketable securities totaled $468.0 million as of September 28, 2008. Management believes this is sufficient to meet requirements for the foreseeable future.
Investor Verification Checklist
- Inventory Valuation: Verify the adequacy of the $119.7 million in inventory reserves and the assumptions used for the $25.0 million provision given the cyclical downturn.
- Acquisition Integration: Monitor the integration progress of Nextest Systems and the closing timeline/financing for the Eagle Test Systems acquisition.
- Restructuring Execution: Track the realization of the projected $8.1 million in quarterly cost savings from restructuring actions.
- Legal Contingencies: Review the status of the Xyratex patent infringement lawsuit and the Herco/Perception Laminates securities fraud appeal.
- Marketability of Investments: Assess the impact of the $8.5 million impairment on marketable securities and potential future impairments in the current economic climate.